InvestorsHub Logo

Den

Followers 787
Posts 99342
Boards Moderated 7
Alias Born 07/05/2006

Den

Re: mc6102 post# 1389

Thursday, 10/18/2012 3:23:56 AM

Thursday, October 18, 2012 3:23:56 AM

Post# of 130508
"This grant will enable Amarantus to explore the full breadth of the MANF opportunity," said Gerald E. Commissiong, President & CEO of Amarantus. "As our development program for Parkinson's progresses towards the critical milestone of identifying the best delivery target(s) for MANF, identifying additional disease targets for MANF therapy could significantly increase the value of our intellectual property portfolio and make Amarantus more attractive to potential partners."

Disclaimer: I post on stocks that I own or am thinking about owning, I am not paid to post about them. If that changes you can find the disclosure in my IRP page. Do your DD, buy and sell based on that DD.